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Members of the estuarine dinoﬂagellate genus
Pﬁesteria are reported to have been responsible
for massive ﬁsh kills between 1991 and 1998,
primarily in the estuaries of North Carolina
and Maryland. The classic signs of Pfiesteria
poisoning in fish are skin ulcerations and
altered, erratic swimming patterns (Burkholder
et al. 1992; Glasgow et al. 1995). The etiology
of the skin ulcers has yet to be determined.
Several theories have been proposed, including
a) that Pﬁesteria complex organisms produce a
potent exotoxin that destroys the integrity of
the skin directly (Glasgow et al. 1995) or
induces necrolysis followed by opportunistic
microbial infection (Burkholder 1999; Noga
et al. 1996); and b) that the dinoflagellate
directly attaches to and feeds on ﬁsh epidermis
(Drgon et al. 2005; Vogelbein et al. 2002).
Another hypothesis is that stress associated
with environmental factors such as a Pﬁesteria
bloom causes severe physiologic dysfunction
that can induce the acute ulceration response
(Udomkusonsri and Noga 2005) and indi-
rectly lead to pathogenic ulceration by water
molds. Other environmental parameters may
also induce the initial lesion that subsequently
becomes infected by water molds (Kiryu et al.
2002; Noga et al. 1996; Udomkusonsri and
Noga 2005). 
The Centers for Disease Control and
Prevention (CDC) includes Pﬁesteria-related
illness in a multiple system syndrome known
as possible estuary-associated syndrome
(PEAS) (Samet et al. 2001). Under the PEAS
criteria, deﬁnitive exposure to estuarine water
bearing pathogenic Pfiesteria must be estab-
lished in concert with the development of
specific symptoms. Although there has been
no indication of toxicity from consumption
of seafood from Pfiesteria-contaminated
waters (Golub et al. 1998), intense occupa-
tional exposure to active ﬁsh-killing Pﬁesteria
species in a laboratory environment or during
a large fish kill event has been reported to
induce headache, disruptions in cognitive
function, and skin lesions (Burkholder 1999;
Glasgow et al. 1995; Grattan et al. 1998).
Initial anecdotal reports suggested that people
who had extensive environmental exposure to
Pﬁesteria-contaminated water or aerosols dur-
ing occupational or recreational aquatic activ-
ities might exhibit ﬂulike symptoms, malaise,
and respiratory and dermal irritation and
inflammation (Grattan et al. 1998; Lowitt
and Kauffman 1998; Shoemaker 1997,
1998). The irritation usually resolved sponta-
neously or by washing with fresh water; sev-
eral investigators suggested that the lesions
might be due to an allergic or toxic reaction
(Grattan et al. 1998; Lowitt and Kauffman
1998). In these exposed individuals, immune,
liver and renal function profiles, blood
chemistries, and blood counts were normal
(Grattan et al. 1998). These initial reports of
human exposure have been criticized because
of the limited number of exposed individuals,
the lack of preexposure data and proper con-
trols, the inability to definitively measure
toxin exposure, the lack of an environmental
screening test for the toxin, the transient
nature of the organism, and confounding
medical and lifestyle factors of many of those
evaluated (Haselow et al. 2001; Moe et al.
2001; Samet et al. 2001). More recently, the
CDC-sponsored, 4-year, cross-sectional stud-
ies in Maryland, Virginia, and North
Carolina found that routine occupational
exposure to estuarine environments contain-
ing Pﬁesteria did not pose any signiﬁcant neu-
ropsychologic health risk (Moe et al. 2001;
Morris et al. 2006). Evaluation of the health
and cognitive function of study participants
in both the preliminary studies and in the
CDC studies attributed the majority of cases
to chronic irritation and trauma associated
with fishing and crabbing work, estuarine
microbes, allergens such as ragweed or pollen,
intense sun and water exposures, and preex-
isting medical and neuropsychologic condi-
tions (Burke and Tester 2002; Collier and
Burke 2002; Haselow et al. 2001; Lowitt and
Kauffman 1998). In two Maryland studies a
small number of skin lesions (seven biopsies
from six patients and eight biopsies from four
patients) were not ascribed to a speciﬁc, alter-
nate diagnosis. Those lesions were biopsied
and exhibited either nonspecific chronic
inflammatory responses or an infiltrate con-
taining eosinophils and lymphocytes (Grattan
et al. 1998; Lowitt and Kauffman 1998). The
nondiagnostic lesions and dermal irritation
that included erythema and an itching, burn-
ing sensation experienced by many people in
multiple studies were deemed significant in
reviews by scientists not associated with the
Maryland studies (Burke and Tester 2002;
Collier and Burke 2002).
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BACKGROUND: Members of the estuarine dinoﬂagellate genus Pﬁesteria are reported to have been
responsible for massive ﬁsh kills in the southeastern United States. Some reports suggest that expo-
sure to waters having Pﬁesteria blooms or occupation-related exposure might result in Pﬁesteria-
induced dermal irritation and inﬂammation. Although the toxin has not been isolated and puriﬁed,
the original data suggested both hydrophilic and hydrophobic toxic components. Some investiga-
tors propose that dermonecrotic properties are associated with a hydrophobic fraction. 
OBJECTIVES: A bioactive C18-bound putative toxin (CPE) extracted from Pﬁesteria-laden aquarium
water during active ﬁsh-killing conditions was examined in the present study to evaluate its poten-
tial to produce inﬂammation and dermal sensitization and to determine whether the inﬂammation
and dermatitis reported in early human exposure studies were allergic or irritant in nature. 
RESULTS: This fraction was cytotoxic to mouse Neuro-2A cells and primary human epidermal
keratinocytes (NHEK) at a concentration of 1 mg/mL. Balb/C mice exposed to 50–200% CPE by
skin painting exhibited a 6–10% increase in ear swelling relative to vehicle-treated mice in a pri-
mary irritancy assay. There was no increase in lymph node cell proliferation as measured using the
local lymph node assay. Exposure to CPE in culture up-regulated interleukin-8 in NHEK, whereas
granulocyte macrophage–colony-stimulating factor and tumor necrosis factor α were only
minimally altered. 
CONCLUSIONS: This study suggests that CPE is cytotoxic to keratinocytes in culture at high concen-
trations and that it induces mild, localized irritation but not dermal sensitization.
KEY WORDS: allergic contact dermatitis, contact irritant dermatitis, cytokines, delayed-type hyper-
sensitivity, keratinocytes, Pﬁesteria, sensitization. Environ Health Perspect 115:1023–1028 (2007).
doi:10.1289/ehp.9559 available via http://dx.doi.org/ [Online 26 February 2007]The exact cause of Pﬁesteria toxicity is still
unknown, although numerous efforts have
been made to isolate the toxin and character-
ize the chemical structure and mechanism of
action (Drgon et al. 2005; Moeller et al.
2001). Cell extracts showed very weak activity
in a panel of bioassays relative to extracts from
Pfiesteria-laden aquarium water, indicating
that the putative toxin(s) is preferentially
released from the cells (Moeller et al. 2001).
Available data suggest both a hydrophilic,
neurotoxic component and a hydrophobic,
dermonecrotic component (Samet et al.
2001), although the relative toxicities of the
components have been contested (Moeller
et al. 2001). A series of studies conducted at
Duke University in Durham, North Carolina,
indicated that the neurotoxic component
might induce subtle, specific deficits in the
acquisition phase of learning and habituation
to the environment in Sprague-Dawley rats
but does not affect other neurologic, hemato-
logic, or histopathologic parameters (Duncan
et al. 2005; Levin et al. 1997, 2003; Rezvani
et al. 2001). The toxic effects diminished
with storage time of the water, suggesting that
the putative toxin degrades quickly (Levin
et al. 1997), possibly because of oxidative
degradation (Moeller et al. 2001).
Earlier studies have associated intense
exposure to Pﬁesteria with a variety of ailments
(Burkholder 1999; Glasgow et al. 1995;
Grattan et al. 1998; Lowitt and Kaufman
1998; Shoemaker 1997, 1998). The eosino-
philic infiltration of dermal lesions, inflam-
mation, and burning sensation reported in
people exposed to Pfiesteria-contaminated
waters suggest potential allergic or irritant
dermatitis. Both allergic contact dermatitis
and contact irritant dermatitis are mediated
by keratinocyte-derived cytokines (Corsini and
Galli 2000). The goal of our present investiga-
tion was to use physical responses and cytokine
proﬁles to assess the potential of a C18-bound
fraction of Pﬁesteria extract (CPE) as an aller-
gen and contact sensitizer and to distinguish a
possible local irritancy response from dermal
sensitization.
Materials and Methods
Animals and treatment. Female Balb/C mice
were obtained from Taconic Farms, Inc.
(Rockville, MD) at 6 weeks of age, maintained
on a 12-hr light/dark cycle at 20–22°C, and
acclimated for 1 week before treatment. The
mice received NIH-31 diet (Ziegler Brothers,
Inc., Gardner, PA) and water ad libitum and
were monitored daily for acute toxicity and
weighed weekly. Treatment had no effect on
the body weight of the mice (data not shown).
We conducted all experiments under an
approved National Institute of Environmental
Health Sciences’ (NIEHS) Animal Care
and Use Committee protocol. The mice
were pathogen free, treated humanely, and
housed in an Association for Assessment
and Accreditation of Laboratory Animal
Care–accredited facility. All experiments using
laboratory animals were conducted with
regard for alleviation of pain and distress.
Production of Pfiesteria extract. A CPE
was produced at North Carolina State
University (NCSU) from the isolate refer-
enced in Litaker et al. (2002), originally
obtained from the Pamlico River in North
Carolina in May 1991. The NCSU culture
contains both Pfisteria piscicida and Pseudo-
ﬁsteria shumwayae and represents the natural
estuarine environment. The CPE was pre-
pared as described by Noga et al. (1996) and
Smith et al. (1988), by exposing tilapia
(Orechromis niloticus) fingerlings to dinofla-
gellate cultures in marine aquaria. The fish
were maintained in 20-L aquaria at room
temperature in 20 ppt artificial seawater
(Instant Ocean; Aquarium Systems, Mentor,
OH) on a 12-hr light:dark cycle in an approved
biocontainment facility with four conditioned
box filters for aeration and nitrification.
Water quality was ammonia < 0.002 mg/L,
pH 8.0–8.2, salinity 20 ppt, and dissolved
oxygen at saturation. The aquarium was
inoculated with the algal culture, and
8–10Tilapia nilotica 2.5– 5 cm in length were
added. As ﬁsh died, more were added to the
aquarium until the bloom had reached a level
sufficient to kill 90–100% of all fish within
48 hr. Time to death of the ﬁsh was used as
the indicator of sample toxicity because it
proved to be a better predictor than algal
counts. The bioactive material was extracted
from the seawater at the peak of the fish-
killing event by adsorption to C18 silica gel.
The aquarium water was pumped into a sepa-
rate vessel and 1 g C18 resin (80 µm; Waters
Corp., Milford MA) was added for every liter
of aquarium water. The resin and aquarium
water were reacted together for 40–60 min
while the magnetic stir bar slowly mixed the
solution to keep the resin suspended. The
resin was allowed to settle; the aquarium
water was aspirated from the vessel; and the
resin was washed with a small volume of clean
20 ppt seawater and transferred to polypropy-
lene tubes. One volume of 40% acetonitrile
(ACN) was added to the resin (ﬁnal concen-
tration, 20% ACN), and the resin was stored
at 4°C in the dark under nitrogen until the
bioactive fraction was eluted. A 2-mL–packed
aliquot of the C18 resin with bound test arti-
cle was poured into a 15-mL Bio-Rad Econo
Pac disposable column (Bio-Rad, Hercules,
CA); the liquid was drained; and the
flowthrough was passed over the resin
5 times. The resin was washed with 20 mL
20% ACN, and the CPE was eluted with
20 mL 100% ACN and dried under nitrogen.
The resulting product from 2 mL of packed
resin resuspended in 3 mL dimethyl sulfoxide
(DMSO) was defined as 100% CPE for
in vivo assays the same quantity of product
resuspended in 1.5 mL DMSO was deﬁned as
200%. To preserve maximal potency, aliquots
of CPE were dried, stored at –80°C, and pre-
pared fresh in DMSO or the appropriate dilu-
tion solvent for each experiment.
Primary irritancy assay. To establish the
minimal irritating and maximal nonirritating
concentrations of the CPE for use in sensiti-
zation experiments and to ensure that the
mice would tolerate multiple days of topical
exposure to the ear, we conducted a primary
irritancy assay following a modiﬁcation of the
method described by Hayes and Meade
(1999). Pretreatment ear thickness was meas-
ured with Oditest (Mitutoyo Co., Kawasaki,
Japan) precision calipers, and 25 µL of CPE
in DMSO or vehicle (DMSO) was applied to
the dorsum of each ear for 3 consecutive days
(days 1, 2, 3). The mice were rested for
2 days. Ear swelling was measured on day 6.
The percent of ear swelling was calculated as
follows: [(posttreatment measure/pretreat-
ment measure) × 100]–100. There were ﬁve
mice per treatment group. 
Local lymph node assay (LLNA). We per-
formed the LLNA according to Interagency
Coordinating Committee on the Validation of
Alternative Methods (ICCVAM) guidelines
(Dean et al. 2001). The mice (ﬁve per treat-
ment group) were treated with CPE by skin
painting as described above. The CPE was dis-
solved in DMSO, and control mice were
treated with DMSO, which is the recom-
mended solvent for water-soluble materials in
the LLNA (Ryan et al. 2002). Ten percent
hexylcinnamaldehyde (HCA), the positive
control, was also prepared in DMSO. On
day 6 the mice were injected intravenously via
the tail vein with 20 µCi of [methyl-3H]-
thymidine (specific activity, 6.7 Ci/mmol;
NEN/PerkinElmer Life Sciences, Boston,
MA) in 250 µL sterile phosphate-buffered
saline (PBS). Five hours later the mice were
euthanized via carbon dioxide asphyxiation
and the cervical (auricular) lymph nodes
(Dean et al. 2001) excised; the same nodes
were removed from each mouse and used in
their entirety for analysis. We prepared a sin-
gle-cell suspension of lymph node cells (LNC)
in PBS for each mouse by grinding the lymph
nodes with the ﬂat end of a 5-cc syringe. The
LNC were washed twice in 10 mL PBS at
4°C. The cell membranes were ruptured,
and the protein-bound DNA was precipi-
tated with 5% trichloroacetic acid (TCA;
Sigma Chemical Co., St. Louis, MO) at 4°C
overnight. After centrifugation, the pellet was
resuspended in 2 mL 5% TCA and transferred
to a scintillation vial containing 18 mL
UltimaGold scintillation fluid (Packard
Instrument Co., Meriden, CT). Incorporation
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lation counting as disintegrations per minute
(dpm) for each mouse. 
Cell proliferation and viability assays.
Primary normal human epidermal ker-
atinocytes (NHEK), obtained from reduction
mammoplasty (BioWhittaker, Walkersville,
MD), were cultured in serum-free, low cal-
cium (0.15 mM) keratinocyte basal medium
(KBM-2; BioWhittaker) supplemented with
epidermal growth factor (0.1 ng/mL), bovine
pituitary extract (0.4%), insulin (5 µg/mL),
hydrocortisone (0.5 µg/mL), gentamicin
(50 µg/mL), and amphotericin (50 ng/mL) in
96-well plates at 1 × 104 cells/well at 37°C
and 5% CO2. Neuro-2A cells [American Type
Culture Collection (ATCC), Manassas, VA]
were cultured in modified minimal essential
medium with Earle’s salts and nonessential
amino acids (MEM, from ATCC), 10% fetal
calf serum, 2 mM glutamine, and (100 U/
100 µg)/mL penicillin–streptomycin in
96-well plates at 2 × 104 cells/well at 37°C
and 5% CO2. Keratinocytes and Neuro-2A
cells were allowed to grow in culture for 24 hr,
then the medium was removed and appropri-
ate dilutions of CPE in fresh medium were
added (n = 6). After 24 hr of exposure to CPE,
the medium was removed and frozen at
–80°C for use in cytokine assays. Cell prolifer-
ation was measured using the CellTiter 96
AQueous One Solution Cell Proliferation Assay
according to the manufacturer’s instructions
(Promega, Madison, WI). Twenty microliters
of the reagent 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium salt (MTS) in 100 µL
fresh medium was added to each well; the cul-
tures were returned to the incubator; and the
absorbance at 490 nm was measured 1, 2, and
3 hr later using a microplate reader and
SoftMax Pro analysis software (Molecular
Devices, Sunnyvale, CA). Cell viability was
measured in NHEK by neutral red dye
uptake. Cells were incubated with 50 µg/mL
neutral red dye in 200 µL fresh medium for
3 hr. The medium-containing dye was
removed and the cells were ﬁxed for 1 min in
200 µL of fixing solution (0.5% formalde-
hyde/0.1% calcium chloride). The ﬁxing solu-
tion was removed, and the dye taken up by
viable cells was extracted with 200 µL 50%
ethanol/1% acetic acid before absorbance
determination at 540 nm, as previously
described (Trouba et al. 2002 ). 
Cytokine assays. The levels of selected
cytokines in cell culture supernatants from
NHEK cultures before the addition of MTS
or neutral red reagent (described above) were
measured using the Luminex xMAP Protein
Immunoassay according to the manufacturer’s
instructions (Biosource, Camarillo, CA).
Brieﬂy, 50 µL of sample was incubated with
50 µL of assay diluent and antibody-coated
beads for 2 hr at room temperature in the dark
with vigorous shaking. After washing, the
samples were incubated with 100 µL biotiny-
lated detection antibody for 1 hr, then with
100 µL streptavidin–R-phycoerythrin (RPE)
for 30 min. Cytokine bead flourescence was
measured and analyzed using the Luminex
LabMAPscanner and software (Biosource).
Two xMAP kits were used. One kit measured
tumor necrosis factor (TNF)-α, granulocyte
macrophage–colony-stimulating factor (GM-
CSF), interleukin (IL)-8, IL-1β, and IL-6 in
supernatants from three different cell culture
experiments; the other measured TNF-α,
GM-CSF, IL-8, macrophage inflammatory
protein (MIP)-1α, and MIP-1β from ﬁve cell
culture experiments. In each experiment, six
culture wells were independently treated for
each group (n = 6). With the ﬁrst cytokine kit,
each culture was assayed independently, that
is, three experiments with six replicates per
group per experiment. Expression levels for
IL-8, IL-1β, and IL-6 were all above the limit
of detection (per the manufacturer’s speciﬁca-
tions) in the ﬁrst assay. IL-1β, and IL-6 data
are presented from this assay. Because TNF-α
and GM-CSF expression levels were generally
below the limit of detection for the assay, two
replicate cultures were pooled and concen-
trated to increase the possibility of detection,
giving three samples per group, that is, five
experiments with three replicates per group
per experiment. All samples from the first
assay were repeated in the second assay. Each
experiment was maintained separately and
there were matched controls for each experi-
ment. After the assay was completed, the data
were pooled for statistical analysis. Data for
TNF-α, GM-CSF, IL-8, MIP-1α, and
MIP-1β are presented from the second assay.
Analysis. We used statistical tests, includ-
ing one- or two-way analysis of variance
(ANOVA), Fisher’s least signiﬁcant difference
(LSD) test, and Dunnett’s test to determine
the significance of the results; we selected a
maximal value of p ≤ 0.05 to determine statis-
tical differences between treatment groups.
We used ANOVA to evaluate overall vari-
ance. Fisher’s LSD is a multiple comparison
test that was used to compare treatment
groups against all other groups. Dunnett’s test
was used to compare treatment groups against
the assay control.
Results
Validation of CPE potency and cytotoxicity.
The effect of CPE on Neuro-2A cell prolifera-
tion was measured to evaluate potency of the
CPE. Earlier studies established Neuro-2A as a
reference cell line that is highly sensitive to
similar Pfiesteria extracts (McClellan-Green
et al. 1997). The dried CPE was not soluble in
water, ACN, or acetone and olive oil 4:1
(AOO), but it formed a suspension at 1 ×
105 µg/mL in 100% DMSO, and was soluble
in culture following serial dilution to 1 ×
103 µg/mL in media containing 1% DMSO.
A pilot experiment demonstrated that 1%
DMSO, 1% AOO, and 1% ACN did not
inhibit cell proliferation in the MTS assay
(data not shown). The MTS compound is
reduced via NADPH or NADH into a solu-
ble, colored formazan product in metabolically
active cells; nonproliferating cells cannot affect
this reaction. CPE induced cytotoxicity in
Neuro-2A cells at 1 × 103µg/mL (Figure 1A).
Diluted CPE retained this activity when dis-
solved in ACN, but in AOO activity was
notably reduced (Figure 1B). CPE was still
cytotoxic to Neuro-2A cells 30 days after
reconstitution but had lost some of its potency
(data not shown), indicating that biological
activity might diminish over time. To preserve
full activity of the extract throughout the
Lack of sensitization by Pfiesteria extract
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Figure 1. Validation of the potency of CPE. The MTS cell proliferation assay was performed as described in
“Materials and Methods.” Con, untreated controls. Brieﬂy, 2 × 104 Neuro-2A cells were cultured 24 hr, then
exposed to CPE for 24 hr. Cell proliferation was quantiﬁed by adding 20 µL of the CellTiter 96 AQueous One
Solution and measuring the absorbance at 490 nm 2 hr later. Twenty percent ACN and 50 ng/mL brevetoxin
(PbTx) served as positive controls. (A) Dose response. Cells were treated with 1 × 10–1 to 1 × 103 µg/mL CPE.
Data values from all experiments were converted to percent of control, with matched controls for each
experiment, and pooled for statistical analysis. Results reﬂect the combination of three full dose–response
curves, each using a different preparation, and a repeat experiment validating the response at 1 × 103 and
1 × 102 µg/mL with the original three preparations and one additional preparation. (B) CPE activity in three dif-
ferent solvents. CPE was dissolved in 1% DMSO, 5% ACN, or 5% AOO at 1 × 103 µg/mL. 
*CPE signiﬁcantly different from control at p ≤ 0.01 with Dunnett’s test. Values represent mean ± SE, n = 37 and 39 sam-
ples for 1 × 103 and 1 × 102 µg/mL, respectively, and n = 16–23 samples for all other treatments in A. **CPE signiﬁcantly
different from vehicle at p ≤ 0.01 with Fisher’s LSD test. Values represent mean ± SE; n = 6 samples for all treatments in B.
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The keratinocyte is the predominant cell
population in the skin, and the release of ker-
atinocyte-derived, proinﬂammatory cytokines
mediates both irritant and allergic contact
dermatitis. Therefore, we evaluated the ability
of CPE to induce cytotoxicity in NHEK. Cell
viability (Figure 2A) and proliferation
(Figure 2B) were both inhibited in primary
cells exposed to CPE at 1 × 103 µg/mL, the
same concentration that was cytotoxic to
mouse Neuro-2A cells. 
CPE-induced contact irritation and sensi-
tization. Because xenobiotic-induced der-
matoses and skin lesions can result from
exposure to both sensitizers and irritants, and
because epidemiologic studies had suggested
both mechanisms as responsible for Pﬁesteria-
induced skin lesions, we examined CPE-
induced dermal irritation and sensitization in
mice using the primary irritancy assay and
local lymph node assay, respectively. Mice
exposed to 50–200% CPE experienced a
6–10% increase in ear swelling relative to
DMSO-treated mice (Figure 3A). No
increase in lymph node cell proliferation was
demonstrated at any concentration of CPE
tested (Figure 3B). Mice treated with DMSO
without CPE served as the control for statisti-
cal comparison. The known sensitizers HCA
(figure 3B) and dinitrofluorobenzene (data
not shown) induced the expected response
when dissolved in DMSO, indicating that
activity was not destroyed by the necessary
use of DMSO as the vehicle.
CPE-induced alterations in cytokine
secretion. Keratinocyte-derived cytokines
mediate inflammatory responses in the skin,
regardless of whether the stimulus is a result
of allergen-speciﬁc or irritant effects, therefore,
we evaluated cytokine proﬁles in NHEK fol-
lowing exposure to CPE (Figure 4). At cyto-
toxic concentrations of CPE (1 × 103 µg/mL),
keratinocytes consistently secreted elevated
levels of IL-8. Secretion of MIP-1α and
MIP-1β was also increased at 1 × 103 µg/mL.
Synthesis of TNF-α was statistically elevated
at 1 × 103 µg/mL, although the average
absorbance value (8.8 pg/mL) was below the
minimum limit of detection for the assay
(10 pg/mL). IL-6, GM-CSF, and IL-1β
expression were not significantly altered by
exposure to CPE.
Discussion
In earlier studies, Pﬁesteria has been reported
to be an extremely toxic marine microbe
(Burkholder et al. 1992, 1999; Glasgow et al.
1995); however, recent studies have intro-
duced several competing theories about toxin
production and potency, and the mechanism
by which the dinoflaggellate kills fish (Berry
et al. 2002; Burkholder et al. 2001; Drgon
et al. 2005; Moeller et al. 2001; Vogelbein
et al. 2002). This study was designed to evalu-
ate the sensitization potential of a CPE
extracted during active fish kill conditions
(90–100% mortality in 48 hr) associated with
a Pﬁesteria isolate in a standard ﬁsh bioassay,
and to determine whether the inflammation
and dermatitis reported in early human expo-
sure studies were allergic or irritant in nature.
At high concentrations, the CPE was cytotoxic
to human keratinocytes, which secrete
cytokines that mediate both allergic and irri-
tant dermatitis. However, in vivo exposure of
mice to CPE induced mild, localized edema
but not lymph node cell proliferation, suggest-
ing that the compound is a mild dermal irri-
tant not a sensitizer. The murine LLNA is a
routinely used, ICCVAM-validated, stand-
alone method for allergic contact dermatitis
hazard identification (Dean et al. 2001).
Baden et al. (2004) conducted an independent
evaluation of a C18-bound extract (Noga-
toxin) derived from the same source culture
used in this study. Consistent with our ﬁnd-
ings, they demonstrated that Nogatoxin puri-
ﬁed using thin-layer chromatography induced
skin erosion and ulceration in ﬁsh but did not
induce clinical signs of toxicity in mice after
oral or intraperitoneal exposure. There were
no changes in airway responsiveness or inﬂam-
matory response in sheep that received
Nogatoxin by tracheal instillation, suggesting
that the compound is not a respiratory sensi-
tizer. Limited structural analysis demonstrated
an absence of aromaticity, countering the
argument of phthalate ester contamination
(Baden et al. 2004). In this study we found
that 20% di(2-ethylhexyl)phthalate did not
induce a response in the primary irritancy
assay or LLNA, compared with the vehicle
control (data not shown). 
Allergic contact dermatitis resulting from
sensitization to an allergen is a T-lymphocyte–
mediated immune response requiring two
temporally distinct exposures (induction and
elicitation), whereas contact irritant dermati-
tis is a localized, reversible, inflammatory
response induced by primary contact with a
Patterson et al.
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Figure 2. CPE-induced cytotoxicity in human keratinocytes. Con, untreated control. 1 × 104 NHEK cells
were treated with 1 × 102 to 1 × 103 µg/mL CPE as previously described. Hanks balanced salt solution
(HBSS) and 20% ACN were used as negative and positive controls, respectively. (A) The neutral red viabil-
ity assay was performed, as described in “Materials and Methods.” Twenty-four hours after exposure to
CPE, cell viability was quantified by adding 50 µg/mL neutral red dye to the medium, fixing the cells,
extracting the dye, and measuring the absorbance at 540 nm. (B) The MTS cell proliferation assay was
performed as described in “Materials and Methods” and Figure 1. 
*CPE signiﬁcantly different from control at p ≤ 0.01 with Dunnett’s test. Results from four experiments were converted to
percent of control and pooled for statistical analysis. Values represent mean ± SE, n = 30 and 23 samples for 1 × 103 and
1 × 102 µg/mL, respectively, and n = 12–18 samples for all other treatments.
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Figure 3. Primary irritancy (A) and lymph node cell proliferation response (B) to CPE in female Balb/C mice.
Values represent mean ± SE, n = 5. (A) The primary irritancy assay was performed as described in
“Materials and Methods.” Brieﬂy, CPE was applied to ears of female Balb/C mice for 3 days. Ear thickness
was measured on days 1 and 6. (B) The LLNA was performed as described in “Materials and Methods.”
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[3H]-thymidine incorporation was measured by liquid scintillation counting. The line at 1,719 dpm represents
a stimulation index of 3.0 (3 times the control value, the biological benchmark of sensitization response). 
CPE signiﬁcantly different from DMSO at *p ≤ 0.01 and **p ≤ 0.05 with Fisher’s LSD test. †HCA signiﬁcantly different from
control at p ≤ 0.01 with Dunnett’s test. 
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Galli 2000). Cytokines are ultimate mediators
of both responses. The primary irritancy reac-
tion in vivo and the cytokine proﬁle in vitro
suggest that the CPE is more likely to be a
mild irritant than a sensitizer. Increased levels
of IL-8, MIP-1α, and MIP-1β, cytokines
associated with irritancy and neutrophil
chemotaxis (Lee et al. 2000; Welss et al.
2004), were secreted by NHEK cultured in
the presence of 1 × 103 µg/mL CPE, but
TNF-α, GM-CSF, and IL-1β, cytokines asso-
ciated with sensitization (Kimber 1996), were
minimally affected. 
Cumulative irritant dermatitis, a common
nonspecific skin disease, is characterized by
erythema, dryness and scaling that are usually
observed with repeated exposure to a mixture
of weak chemicals (Smith et al. 2002). Several
models of irritant-induced inflammation
include initial epithelial damage followed by
either the release of cytokines by epithelial
cells or the direct chemical effect on the
underlying, exposed inflammatory cells
(Smith et al. 2002; Welss et al. 2004). One
plausible model for CPE-induced dermal irri-
tation may be that the lipophilic CPE per-
turbs the lipid bilayer of epithelial cell
membranes, altering membrane fluidity and
receptor-mediated signal transduction. With
this model, IL-1α would be up-regulated and
subsequently induce secretion of IL-8, a
chemotactic cytokine that recruits neutrophils
and lymphocytes to the site of exposure
(Welss et al. 2004). Secretion of IL-8 by kera-
tinocytes after exposure to CPE supports this
theory. Additionally, the response to neutral
red uptake in this study suggests that CPE
may damage membrane integrity. Neutral red
penetrates the membranes of viable cells by
nonionic diffusion and accumulates in the
lysosomes; alterations to the cell surface or
lysosomal membranes lead to irreversible
damage and decreased dye uptake (NIEHS
2001). Melo et al. (2001) demonstrated that a
different Pﬁesteria extract preparation altered
the permeability of rat pituitary cells. 
Both human and animal studies have
demonstrated that irritancy can act as an
adjuvant to skin sensitization (Smith et al.
2002). At low-to-moderate levels, irritant
exposure in conjunction with allergen expo-
sure may lower the threshold for sensitization,
increase the frequency of sensitization (both
induction and elicitation phases), increase the
degree of edema and erythema, and enhance
the proliferative response of lymph node cells.
The lack of such responses in these studies
may result from the absence of co-treatment
with a documented sensitizer. Rodent studies
using a putative hydrophilic neurotoxin 
indicated that bioactive extracts from both 
P. piscicida and P. shumwayae potentiated the
learning, memory, attention, and behavior
alterations induced by the anticholinergic
drug scopolamine in rats (Duncan et al.
2005). Our results suggest that although tran-
sient irritancy induced by exposure to
Pfeisteria-laden water might exacerbate the
response to a true sensitizer, enhancing the
dermatitis, inﬂammation, and lesions caused
by other microorganisms, allergens, and occu-
pational activities, the CPE tested is not capa-
ble of inducing dermal sensitization at the
concentrations evaluated. These findings are
consistent with recent reviews and the CDC-
sponsored epidemiology studies (Moe et al.
2001; Morris et al. 2006) that attributed
reported symptoms to other common causes
and concluded that exposure to Pfiesteria-
containing estuarine environments does not
pose a signiﬁcant health risk.
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Figure 4. CPE-induced cytokine secretion in human keratinocytes. Cell culture supernatants from NHEK cells
treated with 1 × 102 to 1 × 103 µg/mL CPE were analyzed for IL-8 (A); MIP-1α and MIP-1β (B); GM-CSF and
TNF-α (C); and IL-1β and IL-6 (D) after incubation with antibody-coated beads, biotinylated detection antibody,
and streptavidin–RPE using the xMAP Protein Immunoassay system, as described in “Materials and Methods.” 
CPE signiﬁcantly different from control at *p ≤ 0.01 and **p ≤ 0.05 with Dunnett’s test. IL-8, MIP-1α, MIP-1β, GM-CSF, and
TNF-α data are pooled from ﬁve different experiments; IL-1β, and IL-6 data are pooled from three different experiments,
as described in “Materials and Methods.”
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